全球患者获得药品市场 – 行业趋势和 2030 年预测

 患者获得药品的市场分析和规模

拒绝管理的重要性日益增加、降低医疗成本的需求日益增长、患者人数激增导致对医疗保险的需求不断增加以及报销政策的降低，这些因素可能会在 2023-2030 年预测期内推动患者获得药品市场的增长。另一方面，新兴医疗保健市场不断增长的应用将带来大量机会，从而导致预测期内患者获得药品市场的增长。

Data Bridge Market Research 分析，2022 年患者用药市场规模为 102 亿美元，预计到 2030 年将达到 172 亿美元，2023 年至 2030 年预测期内的复合年增长率为 6.75%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

患者获取药品的市场范围和细分  

Market Definition

A pharmaceutical drug, also known as a medication or medicine, is a chemical substance used to treat, cure, prevent, diagnose, or promote health. Drugs were traditionally obtained through the extraction of medicinal plants, but more recently through organic synthesis.

Patient Access with Pharmaceutical Drugs Market Dynamics

Drivers

• Rise in chronic diseases

The number of people who have chronic diseases such as rheumatoid arthritis, hypertension, diabetes, and cancer has increased as a result of the ageing population. The growth of the market during this time was significantly impacted by the demand for pharmaceuticals used to treat these diseases, which was driven by the expansion of the patient pool. These are the certain reasons which propel the market growth.

• New Methods for Drug Discovery

During the forecast period, new technologies, including stem cell and organ chip technologies will propel the pharmaceutical medicines industry. Drug trials are being conducted differently as a result of stem cell and organ-on-chip technology. Micro-engineered biometric devices called "organ on chips" imitate organ systems' functions, mechanics, and physiological reactions. Organ on chip and stem cell technologies are used in drug trial processes such target discovery, validation, target based screening, and phenotypic screening. These technologies are significantly lowering the expenses associated with drug discovery and producing accurate predictions of therapeutic effectiveness and human safety. Therefore, it is anticipated that the pharmaceutical pharmaceuticals market will be driven by inexpensive drug discovery costs and precise findings produced by these technologies.

Opportunities

• Use of biomarker for drug development

Biomarkers are increasingly being used by pharmaceutical companies in the drug development process to shorten the time it takes to bring a product to market. Biomarkers objectively measure and evaluate biological indicators for biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. They can predict drug efficacy faster than traditional clinical endpoints, which are the points at which an unwanted or abnormal effect of the drug is observed, indicating withdrawal from therapy. Companies like Genentech and Janssen are investing more in biomarkers to better understand the efficacy of a potential respiratory drug. Janssen, for example, collaborates with U-BIOPRED (unbiased biomarkers in the prediction of respiratory disease outcomes), a European group dedicated to learning more about severe respiratory disease.

Restraints/Challenges

• High costs of drugs

The high cost of drugs is a major issue for citizens in many countries. There is a lot of pressure to cut costs and show value. Political uncertainty and persistent economic stress in many countries are jeopardizing public health care funding. In less developed countries, a lack of cost-effective drugs has influenced population health and resulted in a low average life expectancy. As a result, pharmaceutical companies in countries such as Chad, Macedonia, and Serbia are under pressure to lower drug prices. The high costs of drugs are putting a strain on pharmaceutical drug manufacturers' revenues.

• Loss of confidentiality and security breaches

Loss of confidentiality and security breaches, as well as a shortage of skilled IT professionals, are likely to hamper the growth of the patient access to pharmaceutical drugs market during the forecast period. The rising cost of deployment and low patient adoption will be the biggest and most pressing challenge to market growth.

This patient access with pharmaceutical drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the patient access with pharmaceutical drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Patient Access with Pharmaceutical Drugs Market Scope

The patient access with pharmaceutical drugs market is segmented on the basis of dimensions, product and service, delivery mode, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Dimensions

• Marketing Approvals
• Time of Marketing Approval
• Coverage
• Cost Sharing
• Conditions of Reimbursement
• Marketing Approval to Reimbursement
• Beneficiaries Control Choice
• Evenness of the Availability of Drugs

Product and Service

• Services
• Support and Maintenance Services
• Implementation Services
• Training and Education Services
• Software
• Eligibility Verification Software
•  Medical Necessity Management Software
•  Pre-certification and Authorization Software
•  Claims Denial and Appeal Management
•  Payment Estimation Software
•  Claims payment assessment and processing software
• Other software

 Delivery Mode

• Web and Cloud-Based Solutions
• On-Premises Solutions

 End User

• Healthcare Providers
• HCIT Outsourcing Companies
• Other End Users

Patient Access with Pharmaceutical Drugs Market Regional Analysis/Insights

The patient access with pharmaceutical drugs market is analyzed and market size insights and trends are provided by country, dimensions, product and service, delivery mode, and end user as referenced above.

The countries covered in the patient access with pharmaceutical drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the patient access with pharmaceutical drugs market due to the growth in healthcare spending, the need to lower healthcare costs, and the proliferation of many healthcare companies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing demand for patient access solutions.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

患者获得药品市场还为您提供了每个国家/地区医疗设备资本支出增长情况的详细市场分析、患者获得药品市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对患者获得药品市场的影响。数据涵盖 2011-2021 年的历史时期。

药品竞争格局及患者获取渠道市场份额分析

患者获得药品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对患者获得药品市场的关注有关。

在患者获得药品市场中运营的一些主要参与者包括：

• MCKESSON 公司（美国）
• Epic Systems Corporation（美国）
• Cerner Corporation（美国）
• Cognizant（美国）
• Experian Information Solutions, Inc.（美国）
• 3M（美国）
• Conifer Health Solutions, LLC（美国）
• Optum, Inc.（美国）
• 顾问委员会中心（美国）
• Craneware 集团 (英国)
• Kareo, Inc（美国）
• SSI Group LLC（美国）
• AccuReg（美国）
• 施乐公司（美国）
• 改变医疗保健（美国）
• Kyruus（美国）
• 康德乐 (美国)

SKU-56962